Sotera Health Co
Sotera Health is a U.S.-based provider of sterilization, laboratory testing, and advisory services for healthcare and life-science supply chains. Its businesses include outsourced terminal sterilization and irradiation, microbiological and analytical testing, and cobalt-60 source supply and related services through Sterigenics, Nelson Labs, and Nordion.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueContract sterilization, irradiation, and validation services for medical, pharma, food, and industrial customers.
Microbiological, analytical chemistry, biocompatibility, toxicology, and regulatory advisory services.
Sale of Co-60 radiation sources plus installation, disposal, and related support services.
Products
Reported · share of revenue- Services85.6 %
- Products14.4 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Customers are primarily medical device manufacturers, pharmaceutical companies, and other healthcare-related producers that need validated sterilization and testing to meet regulatory requirements. The company also serves food, agricultural, and advanced materials customers, while Nordion sells Co-60 to medical equipment makers and sterilization service providers. Relationships are typically recurring because customers embed these services into manufacturing and quality-control workflows.
Buy sterilization, validation, and lab testing to meet device safety and regulatory requirements.
Buy microbiological testing, extractables/leachables, packaging validation, and sterilization support.
Use irradiation services for product safety and shelf-life or contamination control.
Use radiation processing for materials such as polymers, semiconductors, and gemstones.
Buy Co-60 sources and related services for gamma irradiation and oncology applications.
Strategy
The company is investing in capacity expansion, Co-60 development, and lab growth to support demand across its three businesses. It also seeks disciplined acquisitions and uses long-duration customer relationships and validation barriers to reinforce switching costs and recurring revenue.
More facility capacity supports customer demand and reduces bottlenecks in mission-critical services.
Reliable isotope supply is central to Nordion's product and service offering.
Expanded testing capabilities support pharma and device customers and deepen recurring relationships.
Acquisitions can broaden capabilities and scale if integrated successfully.
Geography
2025Sotera Health operates globally, with customers in more than 50 countries and 62 facilities worldwide. The United States is an important operating base, but the business also depends on international manufacturing sites, cross-border supply chains, and global regulatory regimes that affect sterilization and testing demand.
Share of the revenue the company reports by geography.
Risks
The business is exposed to supply, regulatory, litigation, and operational risks because its services rely on hazardous materials and strict compliance standards. It also faces foreign exchange, leverage, and competitive risks, including substitution toward alternative sterilization technologies and customer insourcing of testing.
- EO litigation and liability claimsImpact: CriticalLikelihood: High
Past and future claims tied to EO emissions and facility operations can create settlement and legal expense.
Exposure: Former and current EO sterilization facilities
- Regulatory compliance and approvalsImpact: HighLikelihood: High
Customers rely on the company to meet government and quality requirements, so failures can disrupt demand.
Exposure: Sterilization and lab testing operations
- EO and Co-60 supply disruption or price inflationImpact: HighLikelihood: Medium
Sterilization and isotope supply are core inputs to the business and may be affected by geopolitics or sanctions.
Exposure: Sterigenics and Nordion
- Leverage and debt covenant constraintsImpact: HighLikelihood: Medium
Debt can limit flexibility and increase sensitivity to operating or legal shocks.
Exposure: Corporate capital structure
- Foreign currency exchange volatilityImpact: MediumLikelihood: Medium
The company serves customers across many countries and reports exposure to FX changes in results.
Exposure: International operations
- Competition and substitutionImpact: MediumLikelihood: Medium
Customers may shift to X-ray sterilization, alternative suppliers, or in-house testing.
Exposure
Accounting
Judgemental itemsSterilization, testing, and product sales may be recognized at different points, affecting quarter-to-quarter comparability.
Impact: Service revenues and product revenues can move differently by period
EO-related claims require judgment on settlement and legal cost estimates.
Impact: Can materially affect operating expense and cash outflows
Hazardous-material facilities require remediation and decommissioning estimates.
Impact: Affects long-lived asset and liability balances
Variable-rate debt is hedged with derivatives to reduce cash flow volatility.
Impact: Affects interest expense and other comprehensive income
Acquisitions and long-lived assets may require impairment testing if performance weakens.
Impact: Could create non-cash charges
Similar listed companies
Publicly listed companies with a comparable business focus.
Natera, Inc.
NTRA · Services-Medical Laboratories
Protara Therapeutics, Inc.
TARA · Biological Products, (No Diagnostic Substances)
Fortrea Holdings Inc.
FTRE · Services-Medical Laboratories
Sanara MedTech Inc.
SMTI · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Co-Diagnostics, Inc.
CODX · Surgical & Medical Instruments & Apparatus
SECTRA
SECT-B · Health Care
Sectra is a technology company focused on improving healthcare and cybersecurity.
Last updated: 24/09/2026